Volume 10, Number 3 (17 2011)                   ijdld 2011, 10(3): 291-298 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

اثربخشی ریپاگلیناید (Novo Norm, Novo Nordisk) در درمان دیابت ملیتوس  پس از پیوند کلیه. ijdld. 2011; 10 (3) :291-298
URL: http://ijdld.tums.ac.ir/article-1-122-en.html

Abstract:   (3586 Views)
This article has no abstract.
Full-Text [PDF 255 kb]   (946 Downloads)    
Type of Study: Research | Subject: General
Received: 2010/09/19 | Accepted: 2011/01/7 | Published: 2013/10/22

Add your comments about this article : Your username or email:
Write the security code in the box

© 2017 All Rights Reserved | Iranian Journal of Diabetes and Metabolism

Designed & Developed by : Yektaweb